founders, Board of directors
Our company was founded by scientists who are driven to find treatments for rare neuromuscular diseases.
Our research, drug programs, and commercial efforts are driven by science.
Our goal is to develop the worlds first gene therapy to treat FSHD using novel patented CRISPRi technology.
There is currently no therapeutic treatment or cure for FSHD.